Abstract #4036

Probing white matter abnormalities in preclinical and early Alzheimer’s disease

Qing Wang^1,2, Yong Wang^1,3,4, Joshua S Shimony¹, Anne M Fagan^2,5, John C Morris^5,6, and Tammie L.S. Benzinger^1,6,7

¹Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, MO, United States, ²Knight Alzheimer's Disease Research Center, St. Louis, MO, United States, ³Obstetrics and Gynecology, Washington University in St. Louis, St. Louis, MO, United States, ⁴Biomedical Engineering, Washington University in St. Louis, St. Louis, MO, United States, ⁵Neurology, Washington University in St. Louis, St. Louis, MO, United States, ⁶Knight Alzheimer’s Disease Research Center, St. Louis, MO, United States, ⁷Neurosurgery, Washington University in St. Louis, St. Louis, MO, United States

Robust neuroimaging biomarker sensitive to the early white matter abnormalities could provide novel insights into the pathogenesis of Alzheimer’s disease (AD), and serve as surrogate measures for disease progression. We demonstrated that novel DBSI white matter abnormality biomarkers strongly correlate with invasive CSF measures of neuronal injuries, and provide specific preclinical measures of WM abnormalities for early diagnostics and accurate assessment of disease-modifying therapies targeting neuro-protection in AD.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.